AI disruption in enterprise software
New AI agents (e.g., Claude) could replace workflow and intelligence systems, potentially impacting Capillary's expansion into adjacent spaces.
medium · analyst_questionCapillary Technologies India Limited — Q3 FY26
Capillary Technologies reported Q3 FY26 revenue of 184 crore, up 16% YoY, with adjusted EBITDA of 30 crore (16.4% margin).
bullish
high
Financial stats pending filing verification
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
US healthcare payer exposure
Concerns about rate pressures in US healthcare could affect a top-5 client, though management clarified no exposure to Medicare/Medicaid and noted member growth of ~50%.
low · analyst_questionDepreciation drag from acquisitions
D&A increased from 13 crore to 19 crore YoY due to the cognitive acquisition, pressuring EBIT margins despite EBITDA expansion.
medium · data_observation